Literature DB >> 30674454

Early retinal neurovascular impairment in patients with diabetes without clinically detectable retinopathy.

Yunkao Zeng1,2, Dan Cao1, Honghua Yu1, Dawei Yang1,2, Xuenan Zhuang1,2, Yunyan Hu1, Juan Li1, Jing Yang1, Qiaowei Wu1,3, Baoyi Liu1,3, Liang Zhang4.   

Abstract

AIMS: To investigate the function and the corresponding neurovascular structures in patients with diabetes without clinically detectable retinopathy. METHODS : Sixty-six patients with type 2 diabetes without retinopathy (NDR) and 62 healthy controls were recruited. The 16 and 32 Tds flicker electroretinography (ERG) was performed using a mydriasis-free, full-field flicker ERG recording device (RETeval). The vessel density (VD) of superficial capillary plexus (SCP) and deep capillary plexus (DCP), FD300 and ganglion cell complex (GCC) thickness in the macula were quantified using optical coherence tomography angiography (OCTA). The retinal nerve fibre layer (RNFL) thickness and the radial peripapillary capillary (RPC) density in the peripapillary area were also measured with OCTA.
RESULTS: Parafoveal and perifoveal VD in both SCP and DCP decreased in NDR group in comparison to control group (all p<0.01). However, macular GCC thickness was comparable between the two groups (p=0.661). Peripapillary RNFL thickness and RPC density were significantly lower in NDR group (p<0.001 and p=0.009, respectively). With regard to ERG parameters, delayed implicit time and decreased amplitude were found in NDR group in comparison to the control group (all p<0.01). In the multiple linear regression analyses, delayed implicit time for 16 and 32 Tds stimuli was significantly correlated with increased HbA1c (β=0.350, p<0.001; β=0.328, p<0.001, respectively) and decreased VD of SCP in the parafoveal region (β=-0.266, p=0.013; β=-0.253, p=0.005, respectively). However, delayed implicit time for 16 and 32 Tds stimuli was not correlated with the thickness of GCC (β=-0.008, p=0.818) in multiple linear regression analyses.
CONCLUSION: Functional and structural impairments have already started in diabetic retina even in the absence of visible retinal lesions. Subtle microvascular abnormalities rather than ganglion cell loss might be associated with early functional changes in NDR patients. Poor control of blood glucose was associated with delayed implicit time of flicker ERG in preclinical diabetic retinopathy. © Author(s) (or their employer(s)) 2019. No commercial re-use. See rights and permissions. Published by BMJ.

Entities:  

Keywords:  diagnostic tests/investigation; electrophysiology; imaging; macula; retina

Mesh:

Year:  2019        PMID: 30674454     DOI: 10.1136/bjophthalmol-2018-313582

Source DB:  PubMed          Journal:  Br J Ophthalmol        ISSN: 0007-1161            Impact factor:   4.638


  43 in total

1.  Schizophrenia and the retina: Towards a 2020 perspective.

Authors:  Steven M Silverstein; Samantha I Fradkin; Docia L Demmin
Journal:  Schizophr Res       Date:  2019-11-07       Impact factor: 4.939

2.  The Single Administration of a Chromophore Alleviates Neural Defects in Diabetic Retinopathy.

Authors:  Volha V Malechka; Jianglei Chen; Rui Cheng; Jian-Xing Ma; Gennadiy Moiseyev
Journal:  Am J Pathol       Date:  2020-04-08       Impact factor: 4.307

3.  Measurement Floors and Dynamic Ranges of OCT and OCT Angiography in Glaucoma.

Authors:  Sasan Moghimi; Christopher Bowd; Linda M Zangwill; Rafaella C Penteado; Kyle Hasenstab; Huiyuan Hou; Elham Ghahari; Patricia Isabel C Manalastas; James Proudfoot; Robert N Weinreb
Journal:  Ophthalmology       Date:  2019-03-08       Impact factor: 12.079

4.  Quantitative analysis of early retinal vascular changes in type 2 diabetic patients without clinical retinopathy by optical coherence tomography angiography.

Authors:  Muhammed Altinisik; Neslihan Sinim Kahraman; Emin Kurt; Huseyin Mayali; Ozcan Kayikcioglu
Journal:  Int Ophthalmol       Date:  2022-01-31       Impact factor: 2.031

5.  Multimodal Imaging Assessment of Vascular and Neurodegenerative Retinal Alterations in Type 1 Diabetic Patients without Fundoscopic Signs of Diabetic Retinopathy.

Authors:  Riccardo Sacconi; Marco Casaluci; Enrico Borrelli; Giacomo Mulinacci; Francesca Lamanna; Francesco Gelormini; Adriano Carnevali; Lea Querques; Gianpaolo Zerbini; Francesco Bandello; Giuseppe Querques
Journal:  J Clin Med       Date:  2019-09-08       Impact factor: 4.241

6.  Microvascular retinal changes in pre-clinical diabetic retinopathy as detected by optical coherence tomographic angiography.

Authors:  Jing Yan Yang; Qian Wang; Yan Ni Yan; Wen Jia Zhou; Ya Xing Wang; Shou Ling Wu; Ming Xia Yuan; Wen Bin Wei; Jost B Jonas
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2020-01-02       Impact factor: 3.117

7.  Early retinal neurodegeneration in preclinical diabetic retinopathy: a multifactorial investigation.

Authors:  Ibrahim Toprak; Semin Melahat Fenkci; Guzin Fidan Yaylali; Cigdem Martin; Volkan Yaylali
Journal:  Eye (Lond)       Date:  2019-10-25       Impact factor: 3.775

8.  Ocular blood flow as a clinical observation: Value, limitations and data analysis.

Authors:  Alon Harris; Giovanna Guidoboni; Brent Siesky; Sunu Mathew; Alice C Verticchio Vercellin; Lucas Rowe; Julia Arciero
Journal:  Prog Retin Eye Res       Date:  2020-01-24       Impact factor: 21.198

9.  Assessment of retinal neurodegeneration with spectral-domain optical coherence tomography: a systematic review and meta-analysis.

Authors:  Ziqi Tang; Ming Yan Chan; Wai Yin Leung; Ho Yeung Wong; Ching Man Ng; Victor T T Chan; Raymond Wong; Jerry Lok; Simon Szeto; Jason C K Chan; Clement C Tham; Tien Y Wong; Carol Y Cheung
Journal:  Eye (Lond)       Date:  2020-06-24       Impact factor: 3.775

10.  Association of serum apolipoprotein B with retinal neurovascular structural alterations in patients with type 2 diabetes: an optical coherence tomography angiography study.

Authors:  Rui Shi; Yao Lu; DanDan Liu; ZhongLan Guo
Journal:  Acta Diabetol       Date:  2021-07-22       Impact factor: 4.280

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.